Fact-checked by Grok 2 weeks ago

Roundup Ready

Roundup Ready refers to a trademarked line of glyphosate-tolerant developed by , engineered to express an that confers resistance to the (the active ingredient in ), allowing farmers to spray fields post-emergence to kill weeds without harming the crop. First commercialized in 1996 with soybeans, the technology expanded to include corn, , canola, , and other varieties, rapidly achieving near-total in major U.S. row crops by the early due to its simplicity in compared to multi-herbicide regimes or mechanical tillage. This innovation facilitated widespread adoption of no-till and reduced-tillage practices, potentially lowering fuel use and while simplifying farm operations, though it also correlated with a marked increase in overall glyphosate application volumes—rising from about 20 million pounds annually in the U.S. pre-1996 to over 280 million pounds by 2016—as farmers relied heavily on a single mode of action. The technology's defining impact stems from its integration of crop genetics with chemical , enabling precise targeting of broadleaf and grass weeds that previously required labor-intensive methods, but this overreliance has driven the evolution of glyphosate-resistant "superweeds" in at least 49 species worldwide, necessitating integrated management strategies and supplemental . Regulatory bodies like the U.S. Environmental Protection Agency have repeatedly affirmed 's safety profile, concluding it is not carcinogenic to humans and exhibits low toxicity when used according to label directions, based on extensive toxicological data. Controversies, however, center on ecological shifts from escalated use, including effects and resistance management challenges, alongside litigation alleging non-disclosure of risks—though empirical reviews emphasize that benefits in stability and operational have outweighed documented drawbacks in aggregate farm economics for adopters.

Development and History

Invention and Early Research

The invention of Roundup Ready technology stemmed from 's pursuit of crops tolerant to , the broad-spectrum herbicide commercialized as in 1974 following its discovery by chemist John E. Franz in 1970. inhibits the plant enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), essential for synthesis, leading to weed death but also limiting its use to pre-planting or non-crop areas. To enable in-crop application, researchers initiated screening programs in the early for glyphosate-insensitive EPSPS variants from soil microbes, identifying tolerant strains through selection on media containing the herbicide as a source. A key breakthrough occurred with the isolation of the cp4 epsps gene from sp. strain CP4, a naturally occurring bacterium exhibiting high glyphosate tolerance due to its robust EPSPS , which bind the with lower affinity while maintaining catalytic efficiency. This gene, encoding a Class II EPSPS, was cloned by scientists and demonstrated functionality in microbial expression systems, producing levels sufficient to confer resistance without requiring overexpression. Early experiments confirmed the cp4 epsps protein's tolerance stemmed from structural differences, including substitutions at key sites, allowing substrate binding despite presence. Initial plant transformation efforts focused on model species like and in the late 1980s, where -mediated insertion of the cp4 epsps gene into the nuclear genome yielded stable, heritable resistance, verified by restored growth on selective media and biochemical assays showing elevated EPSPS activity. These proof-of-concept studies paved the way for agronomic crops, with filing patents for the CP4 EPSPS enzyme and its applications, such as U.S. Patent 5,633,435 granted in 1997 (filed 1992), establishing the molecular foundation for commercial Roundup Ready varieties. Field trials of transformed soybeans began around 1991, confirming efficacy against weeds without crop injury.

Commercial Launch and Expansion

Monsanto commercially launched Roundup Ready soybeans in the United States in 1996, representing the first major introduction of glyphosate-tolerant genetically engineered crops to the market. This followed regulatory approvals and limited field trials, with the soybeans engineered to express a bacterial enzyme conferring resistance to glyphosate, allowing post-emergence herbicide application without crop damage. Expansion occurred swiftly thereafter, with Roundup Ready canola first planted commercially in in 1996 on about 50,000 acres. Roundup Ready entered commercial production in the U.S. in 1997, adopted on over 800,000 acres in its initial year, providing growers with simplified in . Roundup Ready corn followed in 1998, extending the technology to a key staple crop and further integrating glyphosate resistance into mainstream . Monsanto facilitated this growth through licensing agreements with seed companies such as Asgrow and , established in the early 1990s, which accelerated trait integration into diverse and varieties. By the early 2000s, the Roundup Ready system had been incorporated into , sugar beets, and other crops, solidifying its role in global herbicide-tolerant crop production.

Genetic Engineering and Mechanism

Molecular Basis of Glyphosate Resistance

Glyphosate exerts its herbicidal action by competitively inhibiting the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), which catalyzes the penultimate step in the responsible for synthesizing the aromatic , , and in and microorganisms. This pathway is absent in animals, making EPSPS a selective . Inhibition occurs through formation of a dead-end involving EPSPS, shikimate-3-phosphate (S3P), and , where mimics the substrate phosphoenolpyruvate (PEP) and binds in an extended conformation at the , preventing the transfer of the enolpyruvyl moiety from PEP to S3P. Plant EPSPS enzymes typically exhibit high to , with inhibition constants () in the range of 0.4–1 μM, leading to accumulation of pathway intermediates like and cessation of production, ultimately causing plant death. Roundup Ready crops achieve glyphosate resistance through transgenic expression of the cp4 epsps gene derived from Agrobacterium sp. strain CP4, encoding the CP4 EPSPS enzyme. This bacterial enzyme maintains catalytic function in the presence of glyphosate concentrations that fully inhibit native plant EPSPS, allowing continued shikimate pathway activity and crop survival. The tolerance stems from kinetic and structural properties that reduce glyphosate's inhibitory efficacy: CP4 EPSPS displays a Ki of 6 mM and IC50 of 11 mM for glyphosate—over 10,000-fold higher than typical plant enzymes—while retaining favorable substrate affinities, such as a Km for PEP of approximately 15 μM. At the structural level, crystal structures of CP4 EPSPS (resolved at 1.7–2.1 Å) reveal that adopts a condensed, non-productive conformation upon , rather than the extended inhibitory pose seen in plant EPSPS. This is primarily due to a key residue at position 100 (Ala-100), which introduces steric hindrance clashing with 's group and Glu-354 in the , destabilizing the inhibitory complex. substituting Ala-100 with glycine (the residue in sensitive plant EPSPS) restores sensitivity, reducing IC50 to 160 μM and enabling extended , confirming Ala-100's causal role. The enzyme also undergoes cation-dependent conformational shifts (e.g., influenced by K+ with a of 25 mM), optimizing activity in planta without compromising tolerance. These features collectively ensure robust resistance without reliance on or other non-target mechanisms observed in evolved weed resistance.

Integration into Crop Genomes

The cp4 epsps gene, isolated from Agrobacterium sp. strain CP4, encodes a glyphosate-tolerant form of the 5-enolpyruvylshikimate-3-phosphate synthase enzyme, which is integrated into the nuclear genome of Roundup Ready crops to enable selective herbicide application without damaging the host plant. This integration typically involves a single copy of the gene cassette, including promoter, coding sequence, and terminator elements (such as the 35S promoter from cauliflower mosaic virus and nopaline synthase terminator), resulting in stable, heritable expression following Mendelian inheritance patterns. The process ensures the transgene is flanked by vector backbone sequences in some events, but functionality relies on precise insertion without disrupting essential host genes. Transformation methods vary by crop species to optimize integration efficiency and regeneration. In soybeans, tumefaciens-mediated delivery is commonly employed, where disarmed strains harboring the binary vector infect or explants, facilitating T-DNA transfer and random chromosomal insertion; this yielded the original GTS 40-3-2 approved in 1994. For corn, (biolistics) predominates, as in the GA21 line, where gold particles coated with DNA (e.g., PV-ZMGT32L) are accelerated into embryogenic cells, promoting direct DNA uptake and integration, often with a maize-optimized EPSPS variant under promoter control. varieties, such as MON 531, utilize Agrobacterium-mediated of meristematic tissues or embryogenic calli, achieving integration sites characterized by analysis to confirm copy number and absence of backbone contamination. Post-integration, selectable markers like the native cp4 epsps itself enable glyphosate-based selection during tissue culture, with regenerated plants screened via PCR or Southern hybridization for stable insertion events. In events like NK603 maize, a single locus insertion into chromosome 6 ensures predictable segregation, while junction sequences at insertion sites have been mapped using techniques such as thermal asymmetric interlaced PCR to verify intactness and lack of unintended rearrangements. Expression levels vary by tissue and genotype due to positional effects at the insertion locus, but efficacy is validated through field trials confirming glyphosate tolerance thresholds exceeding 10-fold over wild-type crops. These methods have been refined since the 1980s, with regulatory dossiers documenting low off-target mutation rates comparable to conventional breeding-induced variations.

Adoption and Market Penetration

Global Adoption Rates

Glyphosate-tolerant crops, including those developed under the Roundup Ready trademark, have seen extensive global deployment, primarily in soybeans, corn, cotton, and canola, where they enable post-emergence application for . As of 2024, the worldwide area planted to biotech crops reached 209.8 million hectares across 28 countries, with herbicide tolerance traits—overwhelmingly conferring resistance—incorporated into the majority of these plantings, often in combination with insect resistance. This represents a continuation of trends where such traits have driven crop expansion, particularly in the and parts of . In the United States, adoption rates for glyphosate-tolerant varieties remain near saturation for principal crops: 94% of acreage, approximately 90% of corn, and 93% of in 2024. , the second-largest adopter, plants glyphosate-tolerant soybeans on virtually all of its GM soybean area, which expanded significantly in recent years, contributing to over 50 million hectares of total GM crops nationally. mirrors this pattern, with glyphosate tolerance dominant in soybeans (exceeding 95% of GM plantings) and increasingly in corn, supporting around 24 million hectares of GM crops. Canada exhibits high adoption of Roundup Ready canola, occupying over 90% of canola acreage, alongside substantial use in corn and soybeans. In , the entire GM soybean crop—comprising the bulk of —is planted with glyphosate-tolerant varieties. Adoption in is concentrated in , where and plant Bt varieties often stacked with glyphosate tolerance on tens of millions of hectares combined, though soybean and corn uptake lags due to regulatory hurdles. and also report adoption rates above 80% for key GM crops like corn and .
Country/RegionKey CropAdoption Rate (Glyphosate-Tolerant, ~2023-2024)Source
Soybeans94%
Corn~90%
93%
SoybeansNearly 100% of GM area
Soybeans>95% of GM area
Soybeans100%
Canola>90%
European countries have negligible commercial adoption due to stringent regulations prohibiting crop cultivation, limiting glyphosate-tolerant varieties to trials or imports for . Globally, while adoption has plateaued in mature markets like the at over 90% for compatible crops, expansion continues in developing regions through approvals for new stacked events.

Crop Varieties and Applications

The primary Roundup Ready crop varieties, genetically modified to express the CP4 EPSPS enzyme conferring glyphosate tolerance, include soybeans, corn, , canola, , and sugar beets, with soybeans introduced first in 1996 followed by canola in 1997, and corn in subsequent years, in 2005, and sugar beets in 2009. These varieties enable post-emergence application of glyphosate herbicides, such as , directly over growing crops to control a broad spectrum of weeds without crop injury, thereby supporting no-till or reduced-tillage practices that minimize . In soybeans, Roundup Ready traits (e.g., event GTS 40-3-2) dominate U.S. planting, with over 90% of acreage utilizing herbicide-tolerant varieties by the mid-2010s, applied in row-crop systems for weed management in high-yield environments like the Midwest. Corn varieties, such as Roundup Ready Corn 2 (event NK603), are stacked with insect resistance traits and used in , , and production, allowing sprays timed to corn growth stages for control of grasses and broadleaf weeds. Cotton Roundup Ready lines (e.g., event MON 88913) facilitate in production across the U.S. , integrating with defoliation practices prior to harvest. Canola Roundup Ready varieties (e.g., event RT73) are applied in oilseed farming primarily in and the northern U.S., where aids in volunteer canola and broadleaf suppression during the crop's short . , via events like MON 00101, supports multiple hay cuttings with selective removal, reducing labor in systems while preserving stand longevity. beets with Roundup Ready traits (e.g., event H7-1) are utilized in root crop rotations for production, enabling effective control of s like kochia that compete during establishment. Across these applications, the technology has been integrated into hybrid breeding programs, often combined with other traits, but requires resistance management to sustain against evolving populations.

Agronomic and Economic Benefits

Yield Improvements and Productivity Data

Empirical studies indicate that Roundup Ready (glyphosate-tolerant, or GT) crops do not inherently possess higher potential than comparable conventional varieties under controlled conditions with effective weed management in both systems. For instance, 1999 variety trials across eight U.S. northern states found Roundup Ready soybeans yielding 97% of conventional counterparts on average, with the gap narrowing from 4% in 1998 as the trait integrated into higher-performing germplasm. Similarly, field trials reported no significant yield differences between Roundup Ready and conventional soybeans when weeds were adequately controlled conventionally. However, at the farm level, adoption of Roundup Ready technology has contributed to improvements primarily through superior , reducing competition and yield losses that often occur with less effective conventional programs. A comprehensive analysis of global farm impacts from 1996 to 2016 attributed additional production of 213 million tonnes to GT traits, with gains ranging from 5% to 11% in the U.S. and for second-generation varieties, and up to 13% to 31% in regions like where baseline pressure was higher. These effects stem indirectly from the flexibility of glyphosate application, enabling timely and comprehensive suppression without crop injury, which preserves potential more consistently than multi- conventional systems. For corn and cotton, similar patterns emerge, with GT varieties delivering yield uplifts of 1% to 15% in corn (e.g., 5% to 15% in the Philippines) and 1.6% to 20% in cotton (e.g., 3% to 20% in Mexico), translating to 405 million additional tonnes of corn and 27 million tonnes of cotton globally over the same period. A 2014 meta-analysis of 147 studies corroborated positive yield effects for herbicide-tolerant GM crops, estimating overall GM adoption (including GT) increased yields by 22% on average, though gains for GT were modestly lower than for insect-resistant traits due to the indirect mechanism via weed management rather than physiological enhancements. Regional variations highlight greater benefits in developing countries, where conventional weed control limitations amplify the relative advantage. Productivity gains extend beyond raw yields to include enhanced overall farm output through integration with conservation practices. Roundup Ready adoption facilitated no-till and reduced-tillage systems, which minimize and improve water retention, contributing to sustained yield stability and long-term productivity increases of several bushels per acre in U.S. corn and rotations. In 2016 alone, GT soybean technology added 32 million tonnes to global , underscoring its role in scaling output amid rising demand.
CropTypical Yield Gain Range (HT Traits)Key Regions/NotesAdditional Global Production (1996–2016, million tonnes)
Soybeans5–31%U.S./Canada: 5–11%; Higher in high-weed areas213
Corn1–15%Indirect via weed control405
Cotton1.6–20%Varies by baseline management27

Cost Reductions and Farming Efficiency

The introduction of Roundup Ready crops, which express tolerance to , has enabled farmers to streamline practices, resulting in measurable reductions in production costs. Global analyses of herbicide-tolerant (HT) , including glyphosate-resistant varieties, attribute approximately 28% of the $261.3 billion in cumulative farm income gains from 1996 to 2020 to cost savings, primarily from decreased herbicide expenditures and simplified protocols. These savings arise as glyphosate's broad-spectrum efficacy allows substitution for multiple conventional , reducing the volume and diversity of chemical applications; for example, U.S. farmers using Roundup Ready soybeans achieved annual cost reductions of $216 million alongside 19 million fewer applications. Farming efficiency has improved through labor and time savings in weed management, as post-emergence glyphosate applications can be timed flexibly without risking damage, minimizing the need for pre-plant or multiple passes with equipment. Meta-analyses confirm that HT crops lower overall costs by 9-37% across studies, depending on regional practices, while enabling systems that cut fuel use by up to 50% in some operations through reduced mechanical weeding. In the U.S., adoption correlated with cost declines for soybeans, though partially offset by higher premiums, yielding net per-acre savings of $5-10 in early years of widespread use. These efficiencies extend to operational scalability, allowing farmers to manage larger areas with fewer resources; for instance, the shift to glyphosate reliance facilitated no-till adoption rates exceeding 50% in HT fields by the mid-2000s, preserving and reducing erosion-related expenses. Empirical data from U.S. Department of Agriculture surveys indicate that bioengineered crop adopters realized variable but positive net returns from input cost reductions, averaging 10-15% lower expenses compared to non-adopters in matched analyses.

Environmental Impacts

Positive Effects on Soil and Tillage

The introduction of glyphosate-tolerant crops, such as Roundup Ready varieties, has facilitated the adoption of conservation practices, including no-till and reduced-till systems, by enabling effective post-emergence without mechanical soil disturbance. This shift reduces the number of tillage passes; for instance, a national survey of U.S. growers found that Roundup Ready adopters performed 25% fewer tillage operations compared to those using conventional varieties. In a 2005-2006 survey of 1,200 growers across six states, 19% transitioned from conventional to conservation tillage following Roundup Ready adoption, with no-till acreage increasing by 16% and reduced-till by 3% overall. Conservation preserves crop residue on the soil surface, substantially lowering erosion rates compared to conventional plowing. No-till systems, supported by glyphosate-tolerant crops, can reduce by up to 90% in row crops like and corn, as residue cover shields soil from wind and water impacts. This practice maintains soil structure and aggregation, minimizing compaction and runoff while enhancing infiltration. In regions like the U.S. , the synergy between herbicide-tolerant crops and no-till has contributed to widespread adoption, with no-till acres rising from about 30% in the mid-1990s to over 60% by the early 2000s following Roundup Ready commercialization in 1996. By limiting soil inversion, these practices promote accumulation of organic matter in the topsoil layers. Reduced tillage disrupts less microbial activity and earthworm populations, fostering higher soil organic carbon levels; the Intergovernmental Panel on Climate Change recognizes no-till cultivation as increasing soil carbon sequestration relative to conventional methods. Empirical analyses link glyphosate-tolerant crop adoption to enhanced carbon storage, with minimal soil disturbance allowing residue incorporation and root biomass retention, potentially sequestering 0.1-0.3 tons of carbon per hectare annually in conservation systems. Overall, these effects improve long-term soil fertility and resilience to drought through better water retention.

Herbicide Resistance and Ecosystem Concerns

The widespread adoption of Roundup Ready crops, which tolerate applications, has exerted strong selective pressure on weed populations, leading to the evolution of glyphosate-resistant biotypes in multiple . The first confirmed case of glyphosate resistance occurred in 1996 with rigid ryegrass (Lolium rigidum) in , predating but accelerated by Roundup Ready commercialization in 1996; by 2024, resistance has been documented in 53 weed across 37 countries, affecting crops like soybeans, corn, and . In the United States, over 30 glyphosate-resistant infest more than 6.2 million hectares of annual cropland, with prevalence in 72% of surveyed fields as of recent assessments. This resistance typically arises via target-site in the EPSPS enzyme or enhanced glyphosate metabolism, enabling weeds like Palmer amaranth () and waterhemp () to survive applications at recommended rates. Herbicide resistance has prompted shifts in practices, often increasing reliance on with different modes of or mechanical tillage to control infestations. In glyphosate-dependent systems, resistant weeds have driven a 20-50% rise in total use in affected regions since the mid-2010s, as farmers layer pre-emergence residuals and post-emergence like or 2,4-D. Effective requires integrated strategies, including , diverse rotations, cover cropping, and precise application timing to delay further evolution; peer-reviewed models indicate that proactive diversification can extend glyphosate utility by 10-20 years compared to single-mode reliance. Without such measures, yield losses from uncontrolled resistant weeds can reach 50-100% in severe cases, particularly for prolific species like Palmer , which produces up to 1 million seeds per plant. Ecosystem concerns stem primarily from these adaptive responses, including potential disruptions to biodiversity from altered weed communities and intensified control tactics. Glyphosate resistance favors dominance by hardy perennials or high-seed producers, reducing overall weed diversity in fields and potentially cascading to non-target effects on soil microbial communities, as glyphosate residues—though short-lived (half-life 2-197 days in soil)—can transiently inhibit beneficial fungi and bacteria at high exposures. In response, reversion to tillage for resistant weed control erodes soil organic matter and increases carbon emissions, countering no-till benefits associated with Roundup Ready systems; studies estimate tillage resurgence could raise soil erosion by 10-20% in resistant-prone areas. Additionally, expanded use of broad-spectrum alternatives may heighten risks to aquatic organisms and pollinators if drift or runoff occurs, though glyphosate's low mammalian toxicity and binding to soil particles limit broad ecosystem persistence compared to more mobile herbicides. Empirical monitoring underscores that while resistance accelerates local biodiversity shifts, integrated management mitigates broader habitat degradation, with no evidence of irreversible ecosystem collapse attributable solely to Roundup Ready adoption.

Health and Safety Evaluations

Empirical Evidence on Human Health

Epidemiological studies of occupationally exposed populations, such as farmers and pesticide applicators, provide the primary empirical data on glyphosate's human health effects, given that Roundup Ready crops facilitate increased glyphosate application. The Agricultural Health Study (AHS), a prospective cohort involving over 89,000 participants in the U.S. from 1993 onward, tracked glyphosate use and cancer incidence among 54,251 applicators, of whom 82.8% reported exposure. Analysis of 5,779 incident cancer cases found no statistically significant associations between glyphosate exposure and overall cancer risk, solid tumors, or lymphoid malignancies, including non-Hodgkin lymphoma (NHL), with hazard ratios near 1.0 even at high cumulative exposure levels. This study's strengths include its large size, long follow-up (up to 20+ years), and reliance on detailed exposure questionnaires rather than retrospective recall, minimizing common biases in case-control designs. Meta-analyses incorporating the AHS and other cohorts generally support these null findings for cancer endpoints. A 2016 systematic review of 14 studies on glyphosate and lymphohematopoietic cancers reported no overall increased risk, with pooled relative risks for NHL at 1.08 (95% CI: 0.91-1.27), though it noted heterogeneity from smaller, recall-biased case-control studies. Regulatory evaluations by the U.S. EPA in 2020 and 2017, drawing on human , concluded glyphosate is "not likely to be carcinogenic to humans," citing insufficient of and confounding factors like co-exposures in positive associations from select meta-analyses (e.g., Zhang et al. 2019, which EPA critiqued for overweighting methodologically weaker studies). Independent reviews, such as a 2023 assessment of NHL , emphasize that positive signals often derive from low-exposure, high-bias studies, while high-exposure cohorts like AHS show no dose-response trends. Beyond cancer, human data on other endpoints remain limited but do not indicate clear risks tied to Roundup Ready-enabled exposures. Prospective studies report no associations with reproductive outcomes, endocrine disruption, or neurological effects in exposed workers, with urinary glyphosate levels in the general population (from dietary residues in Roundup Ready crops) typically below 1-2 μg/L and declining post-application. studies confirm higher occupational exposures but link them to no elevated all-cause mortality or cardiovascular events in large cohorts, countering smaller cross-sectional claims of associations (e.g., via mediation). For the trait itself, compositional analyses of Roundup Ready crops show no unintended allergens or toxins, with protein profiles equivalent to conventional varieties, and no epidemiological signals of increased rates since their 1996 introduction. Controversies persist due to conflicting classifications, such as the IARC's "probably carcinogenic" label based on limited from five studies, which regulators like EFSA and EPA rejected for ignoring negative data and mechanistic weaknesses. Case-control studies occasionally report elevated NHL odds ratios (e.g., 1.4-1.7 in high-exposure groups), but these are prone to —where cases over-report exposures—and fail replication in prospective designs. Overall, the weight of high-quality , prioritizing prospective cohorts over ones, indicates no causal link between from Roundup Ready systems and adverse health outcomes at observed exposure levels.

Glyphosate Toxicology and Regulatory Findings

, the active ingredient in herbicides used with Roundup Ready crops, inhibits the 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) essential for the in plants and microbes, but absent in mammals, resulting in low to humans with an oral LD50 exceeding 5,000 mg/kg in rats. Chronic dietary exposure studies in animals show no-observed-adverse-effect levels (NOAELs) typically above 100 mg/kg/day, supporting regulatory acceptable daily intakes (ADIs) of 0.5 mg/kg body weight by the EPA and 0.3 mg/kg by the EFSA. In genetic toxicology assessments, glyphosate demonstrates no consistent evidence of mutagenicity or clastogenicity across bacterial, mammalian cell, and in vivo assays, with the National Toxicology Program concluding in April 2025 that genotoxic mechanisms are unlikely to drive carcinogenicity. Regarding carcinogenicity, the International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" (Group 2A) in 2015 based on limited evidence from animal tumors and human epidemiology, primarily non-Hodgkin lymphoma associations. However, this hazard-based assessment diverges from risk evaluations by regulatory agencies; the EPA's 2020 review of over 100 chronic rodent studies and epidemiology found glyphosate "not likely to be carcinogenic to humans," citing inadequate evidence for tumor causation and confounding factors in observational data. Similarly, the EFSA's 2015 conclusion, reaffirmed in subsequent renewals, deemed classification unwarranted due to lack of genotoxicity and inconsistent tumor patterns across sexes, strains, and studies not supporting a glyphosate-specific mode of action. Epidemiological meta-analyses, including those by the EPA, show no statistically significant cancer risk elevation at typical agricultural or residential exposures, with relative risks near or below 1.0 for after adjusting for confounders like prior use. Regulatory profiles also dismiss endocrine disruption claims, as lacks binding affinity to hormone receptors and shows no reproductive or developmental effects at doses below maternal thresholds in multi-generational studies. The EPA's 2020 interim registration review decision affirmed no human health risks from current uses, including in Roundup Ready systems, with margins of exposure exceeding 100-fold for applicators and dietary consumers. EFSA's ongoing assessments, including the 2023 renewal process, maintain and carcinogenicity negatives, though eye irritancy and classifications persist for formulated products. Divergences like IARC's arise from methodological differences—IARC emphasizing hazard potential without full exposure context or all regulatory-submitted studies—while agencies like EPA and EFSA integrate comprehensive datasets from and sources, prioritizing weight-of-evidence over selective emphasis. Post-market , including of urinary levels (typically <1-3 µg/L in general populations), aligns with predicting negligible adverse effects below reference doses. As of 2025, no peer-reviewed overturns regulatory findings of safety for approved uses.

Controversies and Criticisms

Health Litigation and Claims

Numerous lawsuits have alleged that exposure to glyphosate, the active ingredient in Roundup herbicide used extensively with Roundup Ready crops, causes non-Hodgkin lymphoma (NHL) and other cancers, primarily filed by agricultural workers and homeowners claiming failure to warn of risks. These claims surged after the International Agency for Research on Cancer (IARC) classified glyphosate as "probably carcinogenic to humans" (Group 2A) in March 2015, based on limited evidence in humans and sufficient evidence in animals, though this assessment has been contested by regulators like the U.S. Environmental Protection Agency (EPA). Bayer, which acquired Monsanto in June 2018, maintains that scientific evidence demonstrates glyphosate does not cause cancer, citing EPA conclusions that it is "not likely to be carcinogenic to humans" when used as directed. The landmark case, Dewayne Johnson v. (2018), involved a groundskeeper who claimed Roundup exposure caused his NHL; a California jury awarded $289 million in August 2018, finding liable for failure to warn and design defect, but the award was reduced to $78 million by the trial judge and further to $20.5 million by the First District Court of Appeal in July 2020, which upheld liability on warning claims while rejecting arguments. Subsequent trials have yielded mixed results: as of September 2025, reports winning 10 of the last 15 bellwether cases, with juries rejecting causation claims in several instances, such as a December 2023 Pennsylvania verdict for the company. However, plaintiffs secured verdicts in eight trials since October 2023, including a $78 million award in Pennsylvania in October 2024. To resolve mounting litigation, has agreed to settlements totaling approximately $11 billion for nearly 100,000 claims as of May 2025, without admitting liability, covering current and future U.S. cases while excluding certain NHL subtypes based on epidemiological data showing no elevated risk. These payouts, averaging under $100,000 per claimant after fees, reflect strategic amid jury unpredictability rather than scientific consensus, as (EFSA) and other bodies align with EPA findings of non-carcinogenicity. Critics of the IARC classification, including regulatory reviews, note its reliance on select studies and potential methodological flaws, contrasting with comprehensive assessments by agencies like Germany's Federal Institute for Risk Assessment (BfR), which reaffirmed safety in 2018 updates. Ongoing appeals and trials continue, with defending over 50,000 unresolved claims as of late 2025.

Anti-GMO Narratives and Debunkings

Opponents of genetically modified (GMOs), including Roundup Ready crops engineered for tolerance, have propagated narratives asserting inherent risks from the genetic modification process itself, such as allergenicity, , or unintended changes leading to novel proteins harmful to consumers. These claims often cite early laboratory studies suggesting compositional differences in GMO crops, but comprehensive reviews of over 1,000 studies by bodies like the National Academies of Sciences, Engineering, and Medicine conclude no substantiated evidence of greater risks to human from GMO foods compared to conventional counterparts. A 2022 of adverse effects from GMO consumption similarly found no credible links to or allergenicity after evaluating peer-reviewed data spanning decades. Another prevalent narrative alleges that Roundup Ready crops exacerbate glyphosate exposure, linking the herbicide to cancer and endocrine disruption, often amplified by the International Agency for Research on Cancer's (IARC) 2015 classification of as "probably carcinogenic to humans" based on limited animal data. However, this assessment has been critiqued for methodological flaws, including selective evidence weighting, and contrasts with epidemiological meta-analyses showing no consistent association between glyphosate exposure and cancer incidence in agricultural workers. Regulatory agencies like the U.S. Environmental Protection Agency (EPA) and (EFSA) have reaffirmed glyphosate's non-carcinogenic status at typical exposure levels, with EFSA's 2023 identifying no critical concerns after analyzing thousands of toxicological studies. Environmental critiques frame Roundup Ready adoption as causing "superweeds" via overreliance on , purportedly devastating and more than conventional farming. While herbicide-resistant weeds have emerged—a predictable evolutionary response to any widely used chemical—meta-analyses indicate GMO herbicide-tolerant crops have reduced overall volume by 37% and enabled no-till practices preserving , countering net claims. Anti-GMO from non-governmental organizations, which often prioritizes precautionary ideology over empirical outcomes, has been linked to retracted studies like the 2012 Séralini paper alleging tumor risks in rats fed Roundup-tolerant , later debunked for poor experimental design and statistical invalidity. Long-term feeding studies and meta-analyses spanning 28 years of commercial GMO deployment, including Roundup Ready varieties, report no verified harm to human or animal , with benefits in stability and reduced outweighing isolated compositional variances. Narratives conflating GMO transgenes with residues overlook that residues in crops remain below maximum residue limits established by regulators, with no causal of population-level health declines attributable to either. These debunkings underscore that anti-GMO positions, while rooted in concerns over novel technology, frequently amplify outlier data while discounting the from rigorous, peer-reviewed and agronomic research.

Regulatory Framework and Intellectual Property

Approvals, Bans, and Ongoing Reviews

Roundup Ready soybeans received regulatory approval for cultivation in the United States after evaluations by the U.S. Food and Drug Administration, U.S. Department of Agriculture, and Environmental Protection Agency, with the EPA specifically approving glyphosate herbicide application on the crop in May 1995. Commercial planting commenced in 1996, marking the introduction of the first glyphosate-tolerant genetically modified crop. Subsequent approvals covered additional crops including maize (e.g., NK603 event in 2000), cotton, and canola, extending to major producers such as Canada (maize approvals ongoing since 1997), Argentina, Brazil, Australia, China, Japan, and Mexico for various events. In the , authorizations have primarily permitted and processing of Roundup Ready crops rather than cultivation. For instance, NK603 glyphosate-tolerant was approved for and feed use in 2009, and Roundup Ready 2 Xtend soybeans for in 2016, following risk assessments by the deeming them substantially equivalent to conventional varieties with no unique hazards. However, cultivation opt-outs by member states, invoking precautionary principles, have effectively banned domestic planting of these crops in countries including , , Austria, Hungary, , and . Explicit bans on GMO cultivation, encompassing Roundup Ready varieties, apply in jurisdictions prioritizing non-GMO . has prohibited both cultivation and imports of GM crops since 2014-2016, citing concerns despite lacking empirical evidence of unique risks beyond approved regulatory thresholds. enacted a 2020 phasing out herbicides and GM corn (including Roundup Ready types) for domestic human consumption and planting by 2024, driven by health policy rather than new safety data, though imports for persist and legal challenges were withdrawn by in June 2024. Regulatory bodies maintain ongoing post-approval surveillance and periodic re-evaluations. The U.S. EPA's 2020 interim registration review reaffirmed 's safety profile, concluding no human health risks from labeled uses, with a comprehensive update scheduled by 2026 incorporating new ecological data on resistance management. In the , renewal until December 15, 2033, includes restrictions on non-professional use and mandates further studies on co-formulants, while GMO events undergo annual reports for unintended effects. These processes emphasize empirical data over divergent classifications, such as the International Agency for Research on Cancer's 2015 "probably carcinogenic" rating, which regulators have critiqued for selective evidence weighting.

Patents, Licensing, and Market Dynamics

secured key for the Roundup Ready technology, including U.S. No. 5,633,435 covering the glyphosate-tolerant CP4 EPSPS inserted into soybeans, which expired in 2014 following the final planting season for the original Roundup Ready 1 (RR1) trait. Similar for Roundup Ready canola expired on April 26, 2022, enabling broader access to the trait in that crop. extended protections through stacked traits and newer iterations, such as Roundup Ready 2 Yield (RR2Y), whose persisted beyond 2014 and covered combinations that prevented immediate generic replication of RR1. Licensing of Roundup Ready technology required farmers to sign Technology/Stewardship Agreements, which granted limited use rights but prohibited , replanting, or transfer without payment of royalties, enforced through contractual clauses and litigation. licensed the traits to seed companies like and Agriscience for integration into their varieties, often under royalty-bearing agreements that expanded trait stacking options while maintaining control over core tolerance. fees were charged per , such as $6.50 per bag for Roundup Ready soybeans and $18 per bag for corn in the mid-2000s, contributing to revenue streams tied directly to . The introduction of Roundup Ready crops drove rapid market adoption, with glyphosate-tolerant soybeans reaching over 90% of U.S. acreage within a decade of 1996 commercialization, reflecting farmers' preference for simplified weed control and cost savings. This dominance correlated with a 15-fold increase in global glyphosate use from 1996 to 2014, as the technology bundled herbicide tolerance with Roundup herbicide sales, creating a locked-in ecosystem. Post-2014 patent expiration for RR1 soybeans, generic versions emerged, reducing Monsanto's exclusivity and prompting shifts to premium stacked traits like Roundup Ready 2 Xtend, which sustained market leadership amid competition from BASF and Syngenta equivalents. Royalty disputes, particularly in Brazil, highlighted tensions, where Monsanto waived fees temporarily to resolve conflicts but pursued collections averaging $23 per acre in some cases.

Recent Developments and Outlook

Litigation Settlements and Industry Responses

Bayer, following its 2018 acquisition of , has settled nearly 100,000 lawsuits alleging that exposure to Roundup's causes and other cancers, with total payouts reaching approximately $11 billion as of May 2025. These settlements, which include a June 2020 agreement covering up to $10.9 billion for around 125,000 claims, do not admit liability, as has consistently cited regulatory findings from agencies like the U.S. Environmental Protection Agency affirming glyphosate's non-carcinogenic status under labeled use conditions. Average individual payouts have ranged from $5,000 to $250,000, often determined by a plaintiff scoring system factoring severity, exposure duration, and other variables, with a typical amount around $150,000–$160,000. Recent developments include Bayer's addition of over $1 billion to its fund on , 2025, and $1.37 billion to litigation reserves in July 2025 to address ongoing claims. Approximately 54,000 cases remain active in multidistrict litigation as of early 2025, though new filings have slowed significantly, with only 135 added in the first eight months of the year. has prevailed in several appeals, including a September 18, 2025, ruling by the Illinois First upholding a in its favor, and continues to defend cases emphasizing over outlier classifications like the International Agency for Research on Cancer's 2015 "probably carcinogenic" determination. In response, has pursued multifaceted strategies to mitigate litigation risks, including appeals to the for preemption under federal , engagement with policymakers to clarify regulatory protections outside the , and efforts to "significantly contain" the litigation by the end of 2026. The company has also lobbied for state and federal legislation granting immunity from certain failure-to-warn claims, arguing that such suits undermine uniform EPA-approved labeling. Operationally, restricted U.S. consumer sales of to licensed professional applicators starting in 2021 and updated product labels to include cancer warnings in select markets, while maintaining that these changes address legal uncertainties without altering its position on 's safety profile supported by over 800 studies. For Ready crops, the has emphasized their role in sustainable weed management, with continued investment in programs to promote responsible use and resistance mitigation, countering narratives linking herbicide-tolerant GM traits directly to health litigation outcomes.

Emerging Technologies and Alternatives

Gene editing technologies, particularly CRISPR/Cas9, have enabled the development of herbicide-tolerant crops with enhanced precision compared to first-generation Roundup Ready varieties, targeting specific genes like acetolactate synthase (ALS) to confer resistance to sulfonylurea herbicides. For instance, in 2020, researchers created a novel OsALS allele in rice using CRISPR/Cas9, allowing tolerance to bispyribac-sodium while minimizing off-target effects. Similar applications in other crops, such as editing ALS genes in basmati rice, demonstrate potential for sustainable weed management by enabling rotation away from glyphosate-dependent systems. These methods address glyphosate-resistant weeds, which affect over 50 weed species globally, by facilitating stacked tolerances without introducing foreign DNA, potentially classifying edited crops as non-GMO in some jurisdictions. Next-generation herbicide-tolerant traits incorporate multiple modes of action, such as Bayer's XtendFlex soybeans approved in 2020, which resist , , and , reducing reliance on single-herbicide systems amid rising resistance. By 2022, such stacked traits covered expanding acreage, with U.S. adoption driven by weeds like Palmer amaranth resistant to since the mid-2000s. These developments integrate with integrated management (IWM), including and cover crops, to delay resistance evolution, as evidenced by field trials showing reduced biomass with diversified use. RNA interference (RNAi)-based approaches offer species-specific alternatives, bypassing the need for crop tolerance by spraying double-stranded to silence essential weed genes like EPSPS, restoring glyphosate susceptibility in resistant populations. Spray-induced (SIGS) trials, advanced by companies like Biosciences, demonstrated foliar RNAi efficacy against weeds in 2025, with minimal environmental persistence due to degradation. Challenges include dsRNA stability under field conditions and regulatory hurdles, but peer-reviewed studies confirm selective silencing without impacting non-target crops, positioning RNAi as a precision tool for post-Roundup Ready eras. Empirical data from 2022-2025 indicate RNAi could complement gene-edited crops, potentially lowering overall volumes by targeting weeds directly.

References

  1. [1]
    How did Roundup Ready and Roundup develop? - GMO Answers
    Sep 28, 2015 · Roundup Ready is a trademark name for a patented line of genetically modified crop seeds that are resistant to the glyphosate-based herbicide, ...<|separator|>
  2. [2]
    History and Outlook for Glyphosate-Resistant Crops - PubMed
    Glyphosate-resistant (GR) crops, commercially referred to as glyphosate-tolerant (GT), started the revolution in crop biotechnology in 1996.
  3. [3]
    Impacts of genetically engineered crops on pesticide use in the U.S.
    Sep 28, 2012 · RR crops were rapidly adopted because they provided farmers a simple, flexible, and forgiving weed management system, especially compared to ...
  4. [4]
    Roundup Ready® Crops: How have they changed things?
    The use of Roundup Ready crops has changed farming practices throughout the country. No-till or reduced-tillage practices have increased dramatically, and are ...
  5. [5]
    Are Roundup Ready weeds in your future?
    The rapid adoption of Roundup Ready (RR) soybeans has grabbed the attention of persons involved directly and indirectly in agriculture.
  6. [6]
    Why Monsanto Thought Weeds Would Never Defeat Roundup - NPR
    Mar 11, 2012 · Monsanto's scientists foresee that weeds would become resistant to glyphosate, the weed-killing chemical in their blockbuster herbicide Roundup.
  7. [7]
    Glyphosate | US EPA
    EPA also found that glyphosate is unlikely to be a human carcinogen. The ID also identified potential ecological risks to non-target organisms, primarily non- ...Basic information on uses · Human health · Food safety · Ecological health
  8. [8]
    Deep dive into the science and history of Monsanto's glyphosate ...
    Feb 12, 2019 · Brought to market by Monsanto in 1974, Roundup lost its patent protection in 2000. Glyphosate remains the world's most commonly used herbicide.
  9. [9]
    John Franz & the Glyphosate Discovery - No-Till Farmer
    Jul 18, 2023 · According to Roundup history by Bayer, Dr. Phil Hamm was the head of Monsanto's herbicide screening program and was excited about two compounds ...
  10. [10]
    Molecular basis of glyphosate resistance: Different approaches ...
    Beginning in the early 1980s, researchers sought to identify glyphosate-insensitive EPSP synthases that could be introduced into crops to provide herbicide ...
  11. [11]
    Variability of CP4 EPSPS expression in genetically engineered ...
    Sep 1, 2018 · Roundup Ready™ varieties contain a gene derived from a naturally-occurring soil microbe, Agrobacterium sp. strain CP4 that encodes the cp4 epsps ...
  12. [12]
    Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
    Genes coding for Class II EPSPS enzymes have been isolated from five (5) different bacteria:Agrobacterium tumefaciens sp. strain CP4, Achromobacter sp. strain ...
  13. [13]
    Genetically transformed tobacco plants expressing synthetic EPSPS ...
    Mar 14, 2017 · The CP4-EPSPS gene expression has been found to confer glyphosate resistance in various crop plants and facilitate more effective weed ...
  14. [14]
    [PDF] Glyphosate-resistant crops: history, status and future
    Abstract: The commercial launch of glyphosate-resistant soybeans in 1996 signaled the beginning of a new era in weed management in row crops.
  15. [15]
    Glyphosate, Roundup and the Failures of Regulatory Assessment
    Jun 13, 2022 · Most genetically-modified crops are designed to tolerate Roundup, thus allowing spraying against weeds during the growing season of the crop ...
  16. [16]
    Trends in glyphosate herbicide use in the United States and globally
    Feb 2, 2016 · Globally, glyphosate use has risen almost 15-fold since so-called “Roundup Ready,” genetically engineered glyphosate-tolerant crops were ...
  17. [17]
    [PDF] This document is the property of Bayer AG and/or any of its affiliates ...
    Roundup Ready canola was first planted commercially in 1996 on 50,000 acres in Canada. In the 2000 growing season, approximately 5.4 million acres (2.2 ...
  18. [18]
    [PDF] Commercial Experience with Roundup Ready Cotton in 1997
    Roundup Ready® cotton (Gossypium hirsutum L.) was introduced commercially in 1997 on over 800,000 acres. When surveyed in September, grower satisfaction ...
  19. [19]
    History of Roundup Ready Crops - SourceWatch
    Aug 19, 2012 · Discovery of Gene​​ Monsanto first began talking about creating "Roundup Ready" crops in the early 1980s, although the first such crops (Roundup ...
  20. [20]
    Closing down on glyphosate inhibition—with a new structure ... - NIH
    Inhibition of EPSPS by glyphosate has been shown to proceed through the formation of an EPSPS-S3P-glyphosate ternary complex and the binding is ordered with ...
  21. [21]
    Molecular basis for the herbicide resistance of Roundup Ready crops
    Aug 29, 2006 · Roundup Ready plants carry the gene coding for a glyphosate-insensitive form of this enzyme, obtained from Agrobacterium sp. strain CP4.
  22. [22]
    Molecular basis for the herbicide resistance of Roundup Ready crops
    Roundup Ready crop lines contain a gene derived from Agrobacterium sp. strain CP4, encoding a glyphosate-tolerant enzyme, the so-called CP4 EPSP synthase (1, 2) ...
  23. [23]
    Desensitizing plant EPSP synthase to glyphosate - NIH
    CP4 EPSPS exhibited a high degree of insensitivity to glyphosate but with a Km for PEP of just 15.5 μm (Table 2), in good agreement with the 12 μm obtained ...
  24. [24]
    Molecular basis for the herbicide resistance of Roundup Ready crops
    Roundup Ready plants carry the gene ... Once incorporated into the plant genome, the gene product, CP4 EPSP synthase, confers crop resistance to glyphosate.
  25. [25]
    [PDF] 00_01101p.pdf - usda aphis
    The insertion resulted in the expression of only the single additional protein of interest, CP4 EPSPS, which imparts tolerance to glyphosate, the active ...
  26. [26]
    [PDF] Assessment of Plant Pest Risk for MON 87705 Soybean - usda aphis
    The CP4 EPSPS protein confers tolerance to glyphosate and has been used in many Roundup Ready crops (e.g. canola, corn, cotton, soybean and sugar beet).
  27. [27]
    Agrobacterium tumefaciens-mediated plant transformation - ISAAA
    Trait Introduction Method: Agrobacterium tumefaciens-mediated plant transformation ... Roundup Ready™ Cotton. Name: MON531 Code: MON-ØØ531-6, Bollgard™ Cotton ...
  28. [28]
    [PDF] NK603 Roundup Ready® Maize - Inf'OGM
    NK603 contains a single insertion of the integrated DNA which is stably integrated into the plant nuclear genome (please see also question 20.(a)). (d) Copy ...
  29. [29]
    Integration and Insertion Site of EPSPs Gene on the Soybean ...
    Aug 5, 2025 · Several junction sequences in transgenic soybean, maize, and cotton were successfully characterized using these methods (Windels et al., 2001; ...
  30. [30]
    [PDF] monsanto - usda aphis
    CP4, was the source of the cp4 epsps gene coding sequence to impart glyphosate ... Roundup and Roundup Ready are registered trademarks of Monsanto Technology LLC.
  31. [31]
    AgbioInvestor-GM
    28 countries planted commercially approved GM crops in 2024, totalling 209.8 million hectares. ... Global GM Crop Area 2024 Review.
  32. [32]
    Herbicide Tolerance Technology: Glyphosate and Glufosinate - ISAAA
    In 2018 alone, HT crops occupied 87.5 million hectares or 45% of the 191.7 million hectares of biotech crops planted globally.
  33. [33]
    Adoption of Genetically Engineered Crops in the United States
    Jan 4, 2025 · A line chart shows the adoption of genetically engineered corn, cotton, and soybeans from their introduction in 1996 to 2024.Missing: impact | Show results with:impact
  34. [34]
    [PDF] Global GM Crop Area Review February 2024
    The rate of adoption of GM crop varieties is effectively mature in the USA, with all GM crops apart from alfalfa having greater than 90% adoption in 2023. As a ...
  35. [35]
    Trends in the global commercialization of genetically modified crops ...
    This article analyzes the global commercialization of GM crops from 1996 to 2023, based on data from the ISSSA and government websites.Missing: Roundup Ready
  36. [36]
    ISAAA Brief 55-2019: Executive Summary
    In 2019, the area planted to herbicide tolerant crops was reduced to 81.5 million hectares or 43%. Some 12% of the global area was planted to insect tolerant ...
  37. [37]
    Rocky Road For Roundup - C&EN - American Chemical Society
    Sep 21, 2015 · Monsanto commercialized the first Roundup Ready seeds ... Monsanto's Roundup Ready seed and glyphosate herbicide—has been a losing bet.Missing: invention | Show results with:invention<|separator|>
  38. [38]
    GM Crop Events List - GM Approval Database - ISAAA.org
    GM Crop Events List (645 Events) ; Name: J101 Code: MON-ØØ1Ø1-8, Roundup Ready™ Alfalfa ; Name: J101 x J163 Code: MON-ØØ1Ø1-8 x MON-ØØ163-7, Roundup Ready™ ...
  39. [39]
    [PDF] Roundup Ready Alfalfa: An Emerging Technology
    Roundup (glyphosate) is a broad-spectrum herbicide that kills a wide range of plants. It is not normally applied directly to crops. The RR technology ...
  40. [40]
    Recommendations for Roundup Ready Alfalfa Weed Management ...
    This publication gives guidelines for managing Roundup Ready alfalfa to prevent gene flow to nearby fields of conventional or organic alfalfa.
  41. [41]
  42. [42]
    Genetically engineered varieties of corn, cotton, and soybeans have ...
    Jul 25, 2016 · Genetically engineered varieties of corn, cotton, and soybeans have plateaued at more than 90 percent of U.S. acreage planted with those crops.
  43. [43]
    Roundup Ready® Corn 2 | Weed Control | Bayer Traits
    Farmers trust in Roundup Ready Corn 2 for season-long protection against common weeds for healthy plants and high yield potential.
  44. [44]
    [PDF] Herbicide-Tolerant Corn in the U.S. is Heavily Treated with ...
    Jul 10, 2024 · Essentially all commercially significant stacked-trait corn varieties are glyphosate tolerant. The total percentage of the U.S. corn crop in any ...
  45. [45]
    Roundup Ready Crops - SourceWatch
    Roundup Ready Crops (RR Crops) are genetically engineered crops that have had their DNA altered to allow them to withstand the herbicide glyphosate.
  46. [46]
    [PDF] History of Roundup Ready Alfalfa - UKnowledge
    In late 1997 Forage Genetics International (FGI) and Monsanto began a joint project to develop Roundup Ready alfalfa. FGI collaborated with Montana State.
  47. [47]
    [PDF] The Economics of Glyphosate Resistance Management in Corn and ...
    However, glyphosate's effectiveness is declining as weed resistance mounts—14 glyphosate-resistant (GR) weed species currently affect U.S. crop-production areas ...
  48. [48]
    [PDF] Glyphosate-Resistant Crops and Weeds: Now and in the Future
    Approximately. 80% of the total area devoted to these crops has been planted with herbicide-resistant crops, virtually all being glyphosate-resistant (GR) crops ...
  49. [49]
    [PDF] Comparing Roundup Ready and Conventional Soybean Yields 1999
    In five of the eight states included in the analysis, the disparity in yields between Roundup Ready and conventional varieties was smaller in the 1999 trials ...
  50. [50]
    [PDF] Roundup Ready Soybeans vs. Conventional Soybeans
    No significant yield differences were found between conventional and Roundup Ready soybeans. Conventional soybeans showed burnt foliage from Roundup drift.
  51. [51]
    Farm income and production impacts of using GM crop technology ...
    Evaluation of the environmental and economic impact of Roundup Ready canola in the Western Australian crop production system, 2009. Curtin University of ...
  52. [52]
    A Meta-Analysis of the Impacts of Genetically Modified Crops
    On average, GM technology adoption has reduced chemical pesticide use by 37%, increased crop yields by 22%, and increased farmer profits by 68%.
  53. [53]
    Farm income and production impacts from the use of genetically ...
    From 1996-2020, GM crops increased farm income by $261.3 billion, with 72% from yield/production gains and 28% from cost savings.Methodology · Herbicide Tolerant (ht)... · Other Ht CropsMissing: efficiency | Show results with:efficiency
  54. [54]
    [PDF] Roundup Ready Soybeans and Bt Field Corn
    Roundup Ready soybeans and Bt field corn have been rapidly adopted by U.S. farmers, yet their approval for commercialization remains under scrutiny.<|separator|>
  55. [55]
    A Meta Analysis on Farm-Level Costs and Benefits of GM Crops
    Our results show that, compared to conventional crops, GM crops can lead to yield increases and can lead to reductions in the costs of pesticide application, ...
  56. [56]
  57. [57]
    [PDF] Size and Distribution of Market Benefits From Adopting Biotech Crops
    This study uses ARMS data on potential crop yield gains and savings in pest control costs after isolating the effects of biotechnol- ogy on these farm-level ...
  58. [58]
  59. [59]
    The contribution of glyphosate to agriculture and potential impact of ...
    ... glyphosate tolerant crops ... The International Panel on Climate Change (IPCC) has agreed that conservation/no till cultivation leads to higher levels of soil ...
  60. [60]
    Correlating Genetically Modified Crops, Glyphosate Use and ... - MDPI
    The removal of tillage and adoption of minimal soil disturbances has reduced the amount of carbon released from tillage and increased the sequestration of ...
  61. [61]
    Status and management of herbicide-resistant weeds in the ... - NIMSS
    Currently, there are > 30 glyphosate-resistant weed species in the United States (Heap, 2024). Several of these GR weed populations (especially Palmer amaranth ...Missing: global | Show results with:global
  62. [62]
    Distribution, frequency, and impact of herbicide-resistant weeds in ...
    Herbicide-resistant weeds occupied 72% of the surveyed fields, corresponding to an estimated 6.2 million ha of annual cropland and a total field area of 11.4 ...
  63. [63]
    Herbicide Resistance: Toward an Understanding of Resistance ...
    Jan 20, 2017 · Review of Glyphosate and ALS-Inhibiting Herbicide Crop Resistance and Resistant Weed Management; Authors: Jerry M. Green; Journal: Weed ...
  64. [64]
    Impacts of Weed Resistance to Glyphosate on Herbicide ... - MDPI
    The primary reason for this sharp increase in herbicide sales was the worsening cases of weeds resistant and tolerant to glyphosate.<|separator|>
  65. [65]
    [PDF] The Economics of Glyphosate Resistance Management in Corn and ...
    To examine economic factors shaping the herbicide-use decisions of crop growers, we combined a biological model of weed growth and glyphosate resistance with ...
  66. [66]
    Utilities and Limitations for Herbicide-Resistant Weed Management
    Jun 29, 2010 · This paper reviews the strengths and weaknesses of anticipated weed management options and the best management practices that growers need to implement in HR ...
  67. [67]
    Glyphosate: Its Environmental Persistence and Impact on Crop ... - NIH
    Nov 13, 2019 · Glyphosate can also predispose plants to diseases indirectly by reducing the overall growth and vigor of the plants, modifying soil microflora ...
  68. [68]
    Exposure risk and environmental impacts of glyphosate
    The current review details the environmental contamination, exposure, health and ecological impacts of glyphosate and glyphosate-based herbicides.
  69. [69]
    Herbicide resistance and biodiversity: agronomic and environmental ...
    Jan 21, 2017 · The adoption of herbicide-resistant crops impacts agronomy, agricultural practice, and weed management and contributes to biodiversity loss in several ways.
  70. [70]
    Herbicide-resistance management: a common pool resource ...
    Feb 20, 2024 · This article analyzes how herbicide resistance fits—and fails to fit—within common pool resource theory and offers an updated conceptual ...<|control11|><|separator|>
  71. [71]
    Glyphosate Use and Cancer Incidence in the Agricultural Health Study
    Nov 9, 2017 · In conclusion, we found no evidence of an association between glyphosate use and risk of any solid tumors or lymphoid malignancies, including ...
  72. [72]
    Cancer Incidence among Glyphosate-Exposed Pesticide Applicators ...
    Glyphosate exposure was not associated with cancer incidence overall or with most of the cancer subtypes we studied.
  73. [73]
    Systematic review and meta-analysis of glyphosate exposure and ...
    This systematic review and meta-analysis rigorously examines the relationship between glyphosate exposure and risk of lymphohematopoietic cancer (LHC)
  74. [74]
    Epidemiologic studies of glyphosate and non-Hodgkin's lymphoma
    Feb 25, 2023 · I reviewed the epidemiologic literature for glyphosate and non-Hodgkin's lymphoma (NHL) in the context of the frequency of exposure in each ...
  75. [75]
    Glyphosate (Roundup): Understanding Risks to Human Health
    Jan 5, 2023 · Based on review of epidemiological studies, the EPA found no evidence of association between glyphosate exposure and numerous cancer outcomes ...Glyphosate Toxicity · Glyphosate Fate In... · Herbicide Regulation
  76. [76]
    Association of Urinary Glyphosate with All-Cause Mortality and ...
    Jul 31, 2024 · Our study indicated that glyphosate was associated with increased all-cause and CVD mortality in humans. Increased ALP may play an essential role in these ...
  77. [77]
    Review of GMO safety assessment studies: glyphosate residues in ...
    Sep 10, 2015 · The study reports high levels of glyphosate residues (Fig. 1) in glyphosate-tolerant soybean (Roundup Ready soy GTS 40-3-2). The study also ...Herbicide-Tolerant Cultivars... · Review Of Published Evidence · Animal Feeding Studies
  78. [78]
    IARC Monograph on Glyphosate
    Jul 19, 2018 · In March 2015, IARC classified glyphosate as “probably carcinogenic to humans” (Group 2A). This was based on “limited” evidence of cancer in humans.
  79. [79]
  80. [80]
    [PDF] US EPA - Glyphosate: Epidemiology Review of Zhang et al. (2019 ...
    Jan 6, 2020 · Zhang et al. (2019). Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma: a meta-analysis and supporting evidence.
  81. [81]
    Glyphosate toxicity and carcinogenicity: a review of the scientific ...
    Apr 3, 2017 · Glyphosate has a relative low long-term dietary toxicity, being within the 10% of herbicides with higher ADI.
  82. [82]
    Differences in the carcinogenic evaluation of glyphosate between ...
    Mar 3, 2016 · EFSA concluded that 'glyphosate is unlikely to pose a carcinogenic hazard to humans and the evidence does not support classification with regard ...
  83. [83]
    Glyphosate & Glyphosate Formulations - National Toxicology Program
    Apr 23, 2025 · Overall, the findings from our genetic toxicity experiments indicate that it is unlikely that glyphosate could cause cancer through a genotoxic ...
  84. [84]
    EPA Finalizes Glyphosate Mitigation | US EPA
    Jan 30, 2020 · EPA has concluded its regulatory review of glyphosate - the most widely used herbicide in the United States. EPA will next complete a draft ...
  85. [85]
    Glyphosate | EFSA - European Union
    Jun 15, 2021 · 30 May 2022 ECHA confirms glyphosate's current hazard classification as causing serious eye damage and being toxic to aquatic life. Based on the ...Missing: EPA 2020-2025
  86. [86]
    Overview of human health effects related to glyphosate exposure
    Glyphosate has been detected in high amounts in workers' urine, but has been detected likewise in bodily fluids, such as blood and maternal milk, and also in 60 ...
  87. [87]
  88. [88]
    EPA and Other Regulators' Assessments of IARC | Bayer Global
    Dec 6, 2024 · The EPA and other international regulators have assessed the scientific data and disagreed with the cancer classification for glyphosate reached in 2015.
  89. [89]
    [PDF] Response to Comments on the Human Health Draft Risk Assessment
    The Agency's conclusion that glyphosate is “not likely to be carcinogenic” is consistent with other countries and regulatory authorities/international ...<|separator|>
  90. [90]
    Managing the Roundup™ Litigation | Bayer Global
    Sep 18, 2025 · ... Roundup™ does not cause cancer. Monsanto has now won ten of the last fifteen cases. Full statement; On December 5, 2023, a jury in the ...
  91. [91]
    Johnson v. Monsanto Co. - Justia Law
    Jul 20, 2020 · The court of appeal affirmed in part. Monsanto was liable on the failure-to-warn claims because substantial evidence was presented that Roundup ...
  92. [92]
    SF Appeals Court Upholds Verdict in Monsanto Roundup Case ...
    Jul 22, 2020 · "We are pleased that the court considered the substantial evidence supporting Mr. Johnson's claims, rejected nearly all of Monsanto's arguments ...
  93. [93]
    Roundup® Cancer Lawsuit | October 2025 Update - Motley Rice
    October 2024: A Pennsylvania man with non-Hodgkin lymphoma was awarded $78 million in a Roundup verdict against Monsanto and parent company Bayer. Roundup is a ...
  94. [94]
    Monsanto Roundup Lawsuit Settlements for Cancer | Oct. 2025
    Oct 10, 2025 · Bayer has paid out nearly $11 Billion in Roundup lawsuit settlements. Since October 2023, there have been 8 successful Roundup verdicts against ...
  95. [95]
    Monsanto Roundup Lawsuit | October 2025 Update
    Oct 1, 2025 · As of May 2025, Monsanto has reached settlement agreements in nearly 100,000 Roundup lawsuits, paying approximately $11 billion. Bayer achieved ...
  96. [96]
    New Evaluations Confirm Glyphosate Not Carcinogenic to Humans
    Mar 1, 2018 · Both BfR and EPA have recently issued updated assessments confirming that a growing body of data do not support any findings that glyphosate is ...
  97. [97]
    Roundup Cancer Settlements | Status Updates & Payouts - King Law
    Oct 15, 2025 · Bayer has settled thousands of Roundup lawsuits, allowing plaintiffs to receive a payout without having to go to trial. A Roundup settlement is ...
  98. [98]
    Evaluation of adverse effects/events of genetically modified food ...
    Jan 13, 2022 · In the latest updated review, he addressed the conclusion that GM soybeans, rice, corn/maize and wheat would be as safe as the parental species ...
  99. [99]
    Glyphosate: no critical areas of concern; data gaps identified - EFSA
    Jul 6, 2023 · The assessment of the impact of glyphosate on the health of humans, animals and the environment did not identify critical areas of concern.Missing: EPA | Show results with:EPA
  100. [100]
    Safety Assessment of Genetically Modified Feed: Is There Any ...
    A meta-analysis including 147 food and feed crops, also has revealed that the adoption of GM technology has decreased the use of chemical pesticides by 37%, ...Missing: peer | Show results with:peer
  101. [101]
    Update on long-term toxicity of agricultural GMOs tolerant to roundup
    Feb 11, 2020 · We found that Roundup contained formulants that were 1000 times more toxic than glyphosate, but these were declared as inert and their identity ...Missing: debunking anti-<|separator|>
  102. [102]
    Full article: Twenty-eight years of GM Food and feed without harm
    Mar 12, 2024 · No new GMO has been proven to be a hazard or cause harm to human consumers. These modifications have improved crop efficiency, reduced losses to insect pests.
  103. [103]
    A Meta-Analysis of the Impacts of Genetically Modified Crops - NIH
    Nov 3, 2014 · On average, GM technology adoption has reduced chemical pesticide use by 37%, increased crop yields by 22%, and increased farmer profits by 68%.
  104. [104]
  105. [105]
    59122 x NK603| GM Approval Database - ISAAA.org
    Oct 18, 2023 · Regulatory Approvals: Country, Year and Type of Approval ; Canada ; Colombia, 2016 ; European Union, 2009 *, 2009 * ; Japan, 2005, 2006 ...
  106. [106]
    EU approves Monsanto, Bayer genetically modified soybeans
    Jul 22, 2016 · The European Commission on Friday approved imports of Monsanto's Roundup Ready 2 Xtend genetically modified soybean variety.
  107. [107]
    Where are GMO crops and animals approved and banned?
    Russia is the most populous country to ban both the cultivation and importation of GMO crops. In 2014, Russia banned the importation of biotech crops, and ...Missing: Roundup | Show results with:Roundup
  108. [108]
    Mexico is banning GE corn and glyphosate, what does that mean for ...
    May 4, 2023 · In 2024, Mexico intends to phase out genetically engineered corn and glyphosate. Mexico is a major importer of US corn, corn that is primarily genetically ...
  109. [109]
    EPA reaffirms conclusion that herbicide glyphosate is safe for ...
    Sep 26, 2022 · EPA reaffirms conclusion that herbicide glyphosate is safe for humans and environment but pledges updated review by 2026. Todd Neeley ...
  110. [110]
    Glyphosate - European Commission's Food Safety
    Glyphosate is currently approved as an active substance in the EU until 15 December 2033 and its use is subject to certain conditions and restrictions.Missing: Ready | Show results with:Ready
  111. [111]
    What is the Impact of Monsanto's Roundup Ready Patent Expiration?
    Jun 11, 2014 · Monsanto's patent on the original Roundup Ready soybean trait is set to expire after the 2014 planting season.
  112. [112]
    Legal Liability of Saving Seeds in an Era of Expiring Patents (FS-1000)
    Jul 20, 2022 · Monsanto's patent on the first generation Roundup Ready©-technology expired in 2014, ending many of the protections Monsanto had under ...
  113. [113]
    Roundup Ready canola patent set to expire | The Western Producer
    Oct 14, 2021 · Bayer's Roundup Ready canola patent expires on April 26, 2022. It was at the heart of a lengthy legal battle between Monsanto, which owned the patent.<|separator|>
  114. [114]
    Post-patent Roundup Ready 1 Era Is Coming - Successful Farming
    Feb 12, 2013 · Monsanto's RR1 trait patent will expire in 2014. However, other patents that may cover or include RR1 soybeans may have different expirations or ...
  115. [115]
    When Can I Start Saving Roundup Ready Soybeans? - Ag PhD
    Dec 14, 2011 · There are two Roundup Ready traits right now: RR1 and RR2Y – The patent on RR1 expires near the end of the growing season in 2014. The patent on ...
  116. [116]
    [PDF] ~Ul1 MONSANTO TECHNOLOGYISTEWARDSHIP AGREEMENT ...
    This Monsanto Technology/Stewardship. Agreement grants Grower a limited license to use Roundup Ready'" soybeans, Genuitv" Roundup Ready 2 Yield" soybeans,.<|separator|>
  117. [117]
    Seeds and Pesticides: Farming Under Corporate Patents | Farm Action
    Sep 25, 2025 · Licensing agreements ban seed saving and tie seeds ... Roundup Ready soybeans signed contracts barring them from saving or reusing the seeds.
  118. [118]
    Monsanto and Corteva Expand Licensing Agreement
    Jun 19, 2018 · The companies have reached an agreement on an expanded license for Roundup Ready 2 Xtend technology for soybeans.
  119. [119]
    Monsanto, Dow Form Licensing Agreement - CropLife
    Monsanto Co. has granted a new royalty-bearing, Roundup Ready 2 Yield license to Dow AgroSciences. The new agreement expands Dow AgroSciences' trait stacking.
  120. [120]
    Monsanto Drops Controversial Technology Fees - No-Till Farmer
    With a cost this year of $6.50 per bag of Roundup Ready soybeans and $18 per bag of Roundup Ready corn, the technology fee got its start in 1966 with the ...
  121. [121]
    Roundup Ready Soybeans: Herbicide-Tolerant Innovation
    Jan 31, 2024 · Roundup Ready soybeans were first commercially planted in 1996, and their adoption rate was unprecedented in agricultural history. By 2006, just ...Missing: expansion | Show results with:expansion
  122. [122]
    Trends in glyphosate herbicide use in the United States and globally
    Feb 2, 2016 · Glyphosate use has risen almost 15-fold since so-called “Roundup Ready,” genetically engineered glyphosate-tolerant crops were introduced in 1996.
  123. [123]
    As Patents Expire, Farmers Plant Generic GMOs
    Jul 30, 2015 · Monsanto says it's not worried about the patent expiration. It developed a new version, Roundup Ready 2, several years ago that it says works ...
  124. [124]
    Roundup Ready 2 Patent Litigation
    Feb 7, 2023 · Monsanto's original patents on genetically modified plants have all expired. But, the company now primarily sells Roundup Ready 2 – Xtend seeds ...
  125. [125]
    Monsanto Waives Soy Royalties in Brazil to Settle Dispute
    Jan 23, 2013 · Monsanto Co., the world's biggest seed company, agreed to waive two years of royalties on its Roundup Ready soybean seeds for Brazilian ...
  126. [126]
    Monsanto Suffers Key Court Loss on Brazil RR1 Royalties
    May 17, 2013 · Earlier this year, a Monsanto representative announced at a farm show in southern Brazil that it would charge R$115 per hectare ($23.28 per acre) ...
  127. [127]
    Roundup Lawsuits | Glyphosate Exposure - Beasley Allen Law Firm
    On June 24, 2020, Bayer announced that it would pay up to $10.9 billion to settle about three-quarters of the 125,000 Roundup cancer claims the company faced.
  128. [128]
    Roundup Settlement: 2025 Weed Killer Settlement Updates
    According to legal experts, the average Roundup settlement payout is $150,000 per plaintiff. Bayer agreed to pay nearly $11 billion to settle Roundup safety ...Roundup Settlement Latest · Settlement Amounts · Settlement Process
  129. [129]
    How Much Will I Get From a Roundup Settlement?
    The average Roundup settlement payout is about $160,000, but individual amounts range from $5,000 to $200,000 based on a scoring system.Scoring Plaintiffs · Pain And Suffering · Punitive Damages
  130. [130]
    Bayer adds $1.37 billion to Roundup litigation reserves, raises 2025 ...
    Aug 1, 2025 · Bayer, which is grappling with costly U.S. product liability litigation, has already paid about $10 billion to settle disputed claims that ...
  131. [131]
    Round Up Litigation: Update for 2025 | Farrell & Fuller
    Now in 2025, while Monsanto has settled nearly 100,000 cases with payouts totaling around $11 billion, approximately 54,000 lawsuits remain active.
  132. [132]
    Roundup Lawsuit (October Update) | Oberheiden P.C
    August 29, 2025 – Bayer is seeking to “significantly contain” the national Roundup litigation by the end of next year, according to reports. AFN reports that ...
  133. [133]
    Bayer's Effort to Block Roundup Lawsuits Kicks Into High Gear
    Apr 8, 2025 · The agrichemical giant Bayer is lobbying for state and federal laws that would give it legal immunity from claims that Roundup causes ...
  134. [134]
    Creating a novel herbicide-tolerance OsALS allele using CRISPR ...
    Jul 24, 2020 · We created a novel herbicide-tolerance allele in rice by targeting the acetolactate synthase (OsALS) gene using CRISPR/Cas9-mediated gene editing.
  135. [135]
    The Development of Herbicide Resistance Crop Plants Using ... - NIH
    Jun 12, 2021 · The CRISPR/Cas technology has an enormous potential as a precise and straightforward genome editing tool to edit the plant genome, which is ...
  136. [136]
    A Review of Herbicide-Tolerant Soybean Trait. Options for 2020
    Bayer's next generation of soybean herbicide-tolerant trait technology is XtendFlex. These soybeans can tolerate over-the-top use of glyphosate, dicamba and ...
  137. [137]
    Full article: Genetically Modified (GM) Crop Use 1996–2020
    Since then there has been a dramatic increase in plantings and by 2020, the global planted area was 185.6 million hectares (ha).
  138. [138]
    Herbicide-Resistant Weeds: Understanding the Challenge and a ...
    Aug 7, 2025 · Ten key IWM strategies include: diversifying herbicide modes of action, using overlapping residuals, rotating crops, incorporating cover crops, ...Missing: alternatives | Show results with:alternatives
  139. [139]
  140. [140]
    Breakthrough in RNA Herbicide Development
    Apr 29, 2025 · GreenLight Bio's RNAi platform of foliar applied sprays precisely targets essential weed plant functions, leaving crops and the surrounding ...Missing: interference | Show results with:interference<|control11|><|separator|>
  141. [141]
    Spray-induced gene silencing for crop protection: recent advances ...
    Feb 20, 2025 · The RNA-based spray-induced gene silencing (SIGS) technology represents an ecologically sustainable approach to crop protection and pathogen management.
  142. [142]
    RNAi technology development for weed control: all smoke and no fire?
    Feb 21, 2025 · RNA interference (RNAi) technology, specifically Spray-Induced Gene Silencing (SIGS), holds potential as an innovative approach for selective weed control.Missing: Roundup | Show results with:Roundup